Lauer Wealth’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,548
Closed -$296K 57
2025
Q1
$296K Sell
4,548
-1,212
-21% -$72.5K 0.23% 35
2024
Q4
$259K Sell
5,760
-243
-4% -$13.6K 0.17% 30
2024
Q3
$341K Sell
6,003
-2,116
-26% -$123K 0.26% 28
2024
Q2
$473K Sell
8,119
-702
-8% -$43.9K 0.37% 22
2024
Q1
$615K Sell
8,821
-94
-1% -$7.18K 0.53% 24
2023
Q4
$659K Sell
8,915
-4,383
-33% -$312K 0.61% 24
2023
Q3
$951K Sell
13,298
-322
-2% -$22.8K 1.03% 18
2023
Q2
$1.03M Buy
13,620
+3,649
+37% +$260K 1.06% 19
2023
Q1
$726K Buy
+9,971
New +$836K 0.91% 18

Other funds holding CVS

Lauer Wealth's CVS Position: Q2 2025 in Review

Lauer Wealth sold out of CVS Health (CVS) in Q2 2025, closing a stake of 4,548 shares — an estimated $296K sold.

Lauer Wealth first reported a position in CVS in Q1 2023 and held it in 9 quarters. The position peaked at $1.03M in Q2 2023. 1,757 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

  • Lauer Wealth reported no remaining CVS Health position as of Q2 2025 after selling out during the quarter.
  • Lauer Wealth sold 4,548 CVS Health shares in Q2 2025, an estimated $296K.
  • Lauer Wealth first reported a position in CVS Health in Q1 2023 and held it in 9 quarters.
  • Lauer Wealth's CVS Health position peaked at $1.03M in Q2 2023.
  • 1,757 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on Lauer Wealth's 13F filing for Q2 2025, filed 13 Aug 2025.